Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis
- PMID: 1601012
- DOI: 10.1007/BF01954384
Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis
Abstract
Orthotopic liver transplantation (OLT) has been proposed to treat patients with type IV glycogenosis because of early progressive cirrhosis. Reports have shown absence of disease progression in other organs after OLT and even regression of cardiac amylopectin infiltration in one case. We describe a 15-month-old child in whom a liver transplant was performed for type IV glycogenosis. There were no clinical signs of extrahepatic disease before OLT. Nine months later, the patient developed progressive cardiac insufficiency and died from cardiac failure. Because of massive amylopectin deposits, decreased myofibrils in cardiac cells, and exclusion of other causes of cardiac failure, death was attributed to amylopectionosis. Our observation contrasts with the Pittsburgh experience and suggests that cardiac amylopectionosis may progress after OLT.
Similar articles
-
Liver transplantation for type I and type IV glycogen storage disease.Eur J Pediatr. 1993;152 Suppl 1(Suppl 1):S71-6. doi: 10.1007/BF02072093. Eur J Pediatr. 1993. PMID: 8319729 Free PMC article.
-
Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease.Liver Transpl Surg. 1995 Nov;1(6):373-6. doi: 10.1002/lt.500010607. Liver Transpl Surg. 1995. PMID: 9346615
-
Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.Acta Neuropathol. 1994;87(5):531-6. doi: 10.1007/BF00294181. Acta Neuropathol. 1994. PMID: 8059607
-
Liver transplantation for glycogen storage disease types I, III, and IV.Eur J Pediatr. 1999 Dec;158 Suppl 2(Suppl 2):S43-8. doi: 10.1007/pl00014320. Eur J Pediatr. 1999. PMID: 10603098 Free PMC article. Review.
-
Nonischemic cardiomyopathy after orthotopic liver transplantation: a report of three cases and a review of the literature.Liver Transpl. 2005 May;11(5):573-8. doi: 10.1002/lt.20410. Liver Transpl. 2005. PMID: 15838869 Review.
Cited by
-
Liver Transplantation for Glycogen Storage Disease Type IV.Front Pediatr. 2021 Feb 19;9:633822. doi: 10.3389/fped.2021.633822. eCollection 2021. Front Pediatr. 2021. PMID: 33681109 Free PMC article. Review.
-
Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison.Am J Hum Genet. 1995 Feb;56(2):359-67. Am J Hum Genet. 1995. PMID: 7847368 Free PMC article. Review.
-
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.Int J Mol Sci. 2023 May 11;24(10):8632. doi: 10.3390/ijms24108632. Int J Mol Sci. 2023. PMID: 37239976 Free PMC article. Review.
-
Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.Pediatr Transplant. 2016 Sep;20(6):756-69. doi: 10.1111/petr.12741. Epub 2016 Jun 21. Pediatr Transplant. 2016. PMID: 27329540 Free PMC article. Review.
-
Glycogenosis type IV: liver transplant at 12 years.Arch Dis Child. 1994 Nov;71(5):450-1. doi: 10.1136/adc.71.5.450. Arch Dis Child. 1994. PMID: 7826120 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical